Baxion
Screening
Tags
Alerts
Theme
Cytomed Therapeutics Ltd.
GDTC
·
NASDAQ
·
$1.15
Share Price as of 11/2
·
$14M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
03/31/26
20-F
Annual report (foreign)
04/28/25
20-F
Annual report (foreign)
04/22/24
20-F
Annual report (foreign)
05/01/23
Disclosures
Filter
6-K
Foreign issuer report
10/13/26
6-K
Foreign issuer report
09/30/26
6-K
Foreign issuer report
06/23/26
6-K
Foreign issuer report
06/03/26
6-K
Foreign issuer report
05/15/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
08/18/25
F-3
Shelf registration (foreign)
06/13/25
S-8
Registration of securities for employees
01/06/25
424B4
Prospectus
04/17/23
FWP
Free writing prospectus
03/31/23
Proxies
Filter
No matching filings.
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/23/26
SC 13D/A
Beneficial ownership (amended)
10/16/26
SC 13D/A
Beneficial ownership (amended)
10/13/26
144
Proposed sale of securities
08/11/26
Form 4
Insider transaction
07/24/26
Other
Filter
EFFECT
Request for effectiveness
06/23/25
CORRESP
Correspondence with the SEC
06/20/25
UPLOAD
Letter from the SEC
06/18/25
CERT
CEO/CFO certification
04/14/23
CORRESP
Correspondence with the SEC
03/31/23
Latest Filings
Filter
6-K
Foreign issuer report
10/13/26
6-K
Foreign issuer report
09/30/26
6-K
Foreign issuer report
06/23/26
6-K
Foreign issuer report
06/03/26
6-K
Foreign issuer report
05/15/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
10/23/26
SC 13D/A
Beneficial ownership (amended)
10/16/26
SC 13D/A
Beneficial ownership (amended)
10/13/26
144
Proposed sale of securities
08/11/26
Form 4
Insider transaction
07/24/26